JR Redman

888 total citations · 1 hit paper
8 papers, 720 citations indexed

About

JR Redman is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, JR Redman has authored 8 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 3 papers in Oncology. Recurrent topics in JR Redman's work include Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (2 papers). JR Redman is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (2 papers). JR Redman collaborates with scholars based in United States. JR Redman's co-authors include Peter McLaughlin, FB Hagemeister, Fernando Cabanillas, F Swan, Sundar Jagannath, Michael Fridrik, P. Salvador, WS Velasquez, S Jagannath and Stephen B. Tucker and has published in prestigious journals such as Blood.

In The Last Decade

JR Redman

8 papers receiving 705 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

1988 487 citations Fernando Cabanillas, P. Salvador et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
JR Redman United States	6	618	396	215	212	119	8	720
Magdalena Adde Sweden	5	502 0.8×	385 1.0×	186 0.9×	203 1.0×	53 0.4×	6	630
CR Kjeldsberg United States	11	511 0.8×	340 0.9×	94 0.4×	229 1.1×	108 0.9×	23	713
PA Bryon France	9	531 0.9×	340 0.9×	79 0.4×	356 1.7×	79 0.7×	18	669
Gaetano Corazzelli Italy	14	493 0.8×	215 0.5×	333 1.5×	320 1.5×	82 0.7×	38	682
R Pearce United Kingdom	7	373 0.6×	312 0.8×	117 0.5×	152 0.7×	43 0.4×	9	576
C. Jonas United States	4	509 0.8×	350 0.9×	87 0.4×	266 1.3×	39 0.3×	9	718
Edward Agura United States	10	352 0.6×	332 0.8×	188 0.9×	120 0.6×	52 0.4×	17	621
Ken Ohmachi Japan	13	403 0.7×	342 0.9×	107 0.5×	211 1.0×	46 0.4×	46	599
Konrad Müller-Hermelink Germany	7	331 0.5×	203 0.5×	138 0.6×	116 0.5×	86 0.7×	8	396
C Ghandour France	11	284 0.5×	189 0.5×	64 0.3×	101 0.5×	82 0.7×	17	390

Countries citing papers authored by JR Redman

Since Specialization

Citations

This map shows the geographic impact of JR Redman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JR Redman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JR Redman more than expected).

Fields of papers citing papers by JR Redman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JR Redman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JR Redman. The network helps show where JR Redman may publish in the future.

Co-authorship network of co-authors of JR Redman

This figure shows the co-authorship network connecting the top 25 collaborators of JR Redman. A scholar is included among the top collaborators of JR Redman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JR Redman. JR Redman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Cabanillas, Fernando, WS Velasquez, FB Hagemeister, Peter McLaughlin, & JR Redman. (1992). Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma. Blood. 79(4). 1024–1028. 32 indexed citations

2.

Cabanillas, Fernando, WS Velasquez, FB Hagemeister, Peter McLaughlin, & JR Redman. (1992). Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma. Blood. 79(4). 1024–1028. 38 indexed citations

3.

Velasquez, WS, Sundar Jagannath, FB Hagemeister, et al.. (1991). Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy. Blood. 77(5). 942–947. 1 indexed citations

4.

Velasquez, WS, Sundar Jagannath, FB Hagemeister, et al.. (1991). Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy. Blood. 77(5). 942–947. 45 indexed citations

5.

Velasquez, WS, Sundar Jagannath, JR Redman, et al.. (1989). Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data. Blood. 74(2). 551–557. 4 indexed citations

6.

Velasquez, WS, S Jagannath, JR Redman, et al.. (1989). Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data. Blood. 74(2). 551–557. 93 indexed citations

7.

Cabanillas, Fernando, P. Salvador, Peter McLaughlin, et al.. (1988). Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood. 71(1). 117–122. 20 indexed citations

8.

Cabanillas, Fernando, P. Salvador, Peter McLaughlin, et al.. (1988). Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood. 71(1). 117–122. 487 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact